Delivery Order SPE2DB22D3016-SPE2DB25FAUF3
Award Date
4/21/25
Potential Completion Date
5/12/25
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $14,346.44 firm fixed-price contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a specialty medication, with a performance period through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,301.05 contract is for the delivery of CABOMETYX 60 MG TABLET 30S, a medical product used in federal healthcare programs. The contract has an ultimate completion date of February 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product, and has a ceiling value of $15,301.05. The contract has an ultimate completion date of April 22, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 firm fixed-price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $93,150.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 20 MG TABLET 30S, a pharmaceutical product, with a completion date of September 29, 2022. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with any set-aside designation, indicating open...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FUZPY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $27,734.36 delivery order contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug CABOMETYX 20 MG TABLET 30S. The contract has a ceiling value of $28,071.28 and an ultimate completion date of September 27, 2024. The contract was awarded on September 6, 2024 and does not have a set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen has been awarded numerous...
This federal contract award is for the delivery of the pharmaceutical product CABOMETYX 60 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 25, 2024, with a ceiling value of $13,908.27 and an ultimate completion date of October 17, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,488.49, is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,035.19, is a firm-fixed-price delivery order for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of a larger...